PuSH - Publication Server of Helmholtz Zentrum München

Hertle, M.L. ; Popp, C. ; Petermann, S. ; Maier, S. ; Kremmer, E. ; Lang, R.* ; Mages, J.* ; Kempkes, B.

Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes.

PLoS Pathog. 5:e1000506 (2009)
Publ. Version/Full Text Volltext DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
The genome of Epstein-Barr virus (EBV) encodes 86 proteins, but only a limited set is expressed in EBV-growth transformed B cells, termed lymphoblastoid cell lines (LCLs). These cells proliferate via the concerted action of EBV nuclear antigens (EBNAs) and latent membrane proteins (LMPs), some of which are rate limiting to establish a stable homeostasis of growth promoting and anti-apoptotic activities. We show here that EBV mutants, which lack the EBNA-3A gene, are impaired but can still initiate cell cycle entry and proliferation of primary human B cells in contrast to an EBNA-2 deficient mutant virus. Surprisingly, and in contrast to previous reports, these viral mutants are attenuated in growth transformation assays but give rise to permanently growing EBNA-3A negative B cell lines which exhibit reduced proliferation rates and elevated levels of apoptosis. Expression profiles of EBNA-3A deficient LCLs are characterized by 129 down-regulated and 167 up-regulated genes, which are significantly enriched for genes involved in apoptotic processes or cell cycle progression like the tumor suppressor gene p16/INK4A, or might contribute to essential steps of the viral life cycle in the infected host. In addition, EBNA-3A cellular target genes remarkably overlap with previously identified targets of EBNA-2. This study comprises the first genome wide expression profiles of EBNA-3A target genes generated within the complex network of viral proteins of the growth transformed B cell and permits a more detailed understanding of EBNA-3A's function and contribution to viral pathogenesis.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
9.125
1.190
56
55
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords EPSTEIN-BARR-VIRUS; NUCLEAR ANTIGEN 3C; LYMPHOBLASTOID CELL-LINE; RBP-J-KAPPA; BURKITTS-LYMPHOMA; TARGET GENES; PROTEIN; PROMOTER; EBNA3A; GROWTH
Language english
Publication Year 2009
HGF-reported in Year 0
ISSN (print) / ISBN 1553-7366
e-ISSN 1553-7374
Journal PLoS Pathogens
Quellenangaben Volume: 5, Issue: 7, Pages: , Article Number: e1000506 Supplement: ,
Publisher Public Library of Science (PLoS)
Reviewing status Peer reviewed
POF-Topic(s) 30203 - Molecular Targets and Therapies
Research field(s) Immune Response and Infection
PSP Element(s) G-501500-002
G-501700-003
PubMed ID 19578441
Scopus ID 70049083050
Erfassungsdatum 2009-12-31